Precision PromiseSM – For Healthcare Professionals
Contact Us

Home Research Precision PromiseSM Precision PromiseSM – For Healthcare Professionals

Pancreatic cancer patients who participate in clinical research have better outcomes1. Clinical trials can advance research and improve treatment options. PanCAN offers clinical trials information personalized for you and your patients.
1PanCAN’s Public Statements for Healthcare Professionals, including references.

We maintain the most comprehensive and up-to-date database of pancreatic cancer clinical trials available in the United States. There are two ways you can access this information to receive available clinical trials that match your patients’ needs:

Healthcare Professional Services

Our team can provide a list of clinical trials personalized to your patient.
Contact Us

Clinical Trial Finder

Run your own search for clinical trials that match your patient’s needs.
Search Trials

Frequently Asked Questions

What is PanCAN’s Precision Promise adaptive clinical trial?

Precision Promise is an adaptive clinical trial sponsored by PanCAN. The novel clinical trial platform utilizes a response-adaptive randomized design to efficiently test new therapies for their effectiveness in treating patients with pancreatic cancer.

PanCAN brings together leading experts and stakeholders – researchers, clinicians, industry and pancreatic cancer thought-leaders – to make this historic initiative possible with the goal to bring new treatment options to patients.

What are the eligibility requirements?

PanCAN’s Precision Promise adaptive clinical trial will enroll patients ≥ 18 years of age with stage IV metastatic pancreatic cancer (PDAC) who are untreated (first line) or have received one prior therapy in the metastatic setting (second line). Please contact a Precision Promise site to find out if your patient is eligible.

What treatment options will be included in PanCAN’s Precision Promise adaptive clinical trial?

Multiple investigational treatment arms will be simultaneously tested through PanCAN’s Precision Promise adaptive clinical trial and compared to multiple standard of care therapies.

In addition to investigating potential new treatment therapies, Precision Promise will also be investigating supportive care measures.

How do I enroll my patient in PanCAN’s Precision Promise adaptive clinical trial?

Contact PanCAN’s Healthcare Professional Services to learn more about which sites are currently open and enrolling.

Additionally, full details about PanCAN’s Precision Promise adaptive clinical trial, including a current listing of all active sites, can be accessed by searching for Precision Promise through our Clinical Trial Finder.

Where is PanCAN’s Precision Promise adaptive clinical trial located, and when will the sites open?

There are 15 initial Clinical Trial Consortium sites across the United States. The sites will start opening in early 2020, with the majority expected to open throughout the year. The Clinical Trial Consortium page will continue to be updated as sites open.

 
Contact Healthcare Professional Services for additional information about Precision Promise and to access free information, resources and services for you and your pancreatic cancer patients.

Contact Healthcare Professional Services

 

PRECISION PROMISESM is a service mark of Pancreatic Cancer Action Network, Inc.

Wage Hope With Us

Join us to make a difference for pancreatic cancer patients.





shop purple logo

Gear, apparel, accessories and more to show off your purple pride.


Shop Now 

©2020 Pancreatic Cancer Action Network. All rights reserved. Terms of Use | Privacy Policy


Pancreatic Cancer Action Network®, PanCAN®, PurpleStride®, Wage Hope®, Know Your Tumor®, Powerful Knowledge. Personal Treatment.®, Precision Promise℠ and Demand Better For Patients. For Survival.℠ are the trademarks of the Pancreatic Cancer Action Network, Inc.


The Pancreatic Cancer Action Network is registered as a 501©3 nonprofit organization. Contributions to the Pancreatic Cancer Action Network are tax-deductible to the extent permitted by law. The Pancreatic Cancer Action Network’s tax identification number is #33-0841281.